Comparison of buserelin and nafarelin in IVF cycles and in subsequent frozen-thawed embryo transfer cycles

References

• Hughes EG, Fedorkow DM, Daya S, Sagle MA, Van de Koppel P, Collins JA. The routine use of gonadotropinreleasing hormone agonists prior to in vitro fertilization and gamete intrafallopian transfer: a meta-analysis of randomized controlled trials. Fertil Steril 1992; 58: 888–96.
   Google Scholar
• Dodson WC, Hughes CL, Whitesides DB, Hanley AF. The effect of leuprolide acetate on ovulation induction with human menopausal gonadotropins in polycystic ovary syndrome. J Clin Endocrinol Metab 1987; 65: 95–100.
   PubMed Web of Science ®Google Scholar
• Loumaye E. The control of endogenous secretion of LH by gonadotropin-releasing hormone agonists during ovarian hyperstimulation for in-vitro fertilization and embryo transfer. Hum Reprod 1990; 5: 357–76.
   PubMed Web of Science ®Google Scholar
• MacLachlan V, Besanko M, O’Shea F, Wade H, Wood C, Trounson A et al. A controlled study of luteinizing hormone-releasing hormone agonist (buserelin) for the induction of folliculogenesis before in vitro fertilization. N Engl J Med 1989; 320: 1233–7.
   Google Scholar
• Smitz J, Camus M, Devroey P, Erard P, Wisanto A, Van Steirteghem AC. Incidence of severe ovarian hyperstimulation syndrome after GnRH agonist/HMG superovulation for in vitro fertilization. Hum Reprod 1990; 5: 933–7.
   Google Scholar
• Testart J, Forman R, Belaisch-Allart J, Volante M, Hazout A, Strubb N et al. Embryo quality and uterine receptivity in in-vitro fertilization cycles with or without agonists of gonadotropin-releasing hormone. Hum Reprod 1989; 4: 198–201.
   Google Scholar
• Oehninger S, Toner JP, Veeck LL, Brzyski RG, Acosta AA, Muasher SJ. Performance of cryopreserved pre-embryos obtained in in vitro fertilization cycles with or without a gonadotropin-releasing hormone agonist. Fertil Steril 1992; 57: 620–5.
   Google Scholar
• Benshushan A, Ezra Y, Simon A, Mordel N, Lewin A, Laufer N. The effect of gonadotropin-releasing hormone agonist on embryo quality and pregnancy rate following cryopreservation. Fertil Steril 1993; 59: 1065–9.
   Google Scholar
• Conn PM, Crowley Jr WF. Gonadotropin-releasing hormone and its analogues. N Engl J Med 1991; 324: 93–103.
   PubMed Web of Science ®Google Scholar
• Goldman JA, Dicker D, Feldberg D, Ashkenazi J, Voliowich I. A prospective randomized comparison of two gonadotrophin-releasing hormone agonists, nafarelin acetate and buserelin acetate, in in-vitro fertilization-embryo transfer. Hum Reprod 1994; 9: 226–8.
   Google Scholar
• Lockwood GM, Pinkerton SM, Barlow DH. A prospective randomized single-blind comparative trial of nafarelin acetate with buserelin in long-protocol gonadotropin-releasing hormone analogue controlled in-vitro fertilization cycles. Hum Reprod 1995; 10: 293–8.
   Google Scholar
• Van Steirteghem AC, Van den Abbeel E, Camus M, Van Waesberghe L, Braeckmans P, Khan I et al. Cryopreservation of human embryos obtained after gamete intra-fallopian transfer and/or in-vitro fertilization. Hum Reprod 1987; 2: 593–8.
   Google Scholar
• Tiitinen A, Husa L-M, Tulppala M, Simberg N, Seppala M. The effect of cryopreservation in prevention of ovarian hyperstimulation syndrome. Br J Obstet Gynaecol 1995; 102: 326–9.
   Google Scholar
• Polson DW, MacLachlan V, Krapez JA, Wood C, Healy DL. A controlled study of gonadotropin-releasing hormone agonist (buserelin acetate) for folliculogenesis in routine in vitro fertilization patients. Fertil Steril 1991; 56: 509–14.
   Google Scholar
• Broekmans FJ, Hompes PGA, Lambalk CB, Schoute E, Broeders A, Schoemaker J. Short term pituitary desensitization: effect of different doses of the gonadotropin-releasing hormone agonist triptorelin. Hum Reprod 1996; 11: 55–60.
   PubMed Web of Science ®Google Scholar
• Pellicer A, Miro F. Steroidogenesis in vitro of human granulosa-luteal cells pretreated in vivo with gonadotropin-releasing hormone analogs. Fertil Steril 1990; 54: 590–6.
   PubMedGoogle Scholar
• Devreker F, Govaerts I, Bertrand E, Van den Bergh M, Gervy C, Englert Y. The long-acting gonadotropin-releasing hormone analogues impaired the implantation rate. Fertil Steril 1996; 65: 122–6.
   Google Scholar
• Chaplin MD. Bioavailability of nafarelin in healthy volunteers. Am J Obstet Gynecol 1992; 166: 762–5.
   PubMed Web of Science ®Google Scholar